Product Images Gabapentin
View Photos of Packaging, Labels & Appearance
- Bottle Label 100 mg - 71610 0421 53
- Aphena Pharma Solutions - TN - Aphena
- Figure 1 - image 01
- Figure 2 - image 02
- Figure 3 - image 03
- Cockcroft and Gault Equation - image 04
- Gabapentin Structural Formula - image 05
- Figure 4. Responder Rate in Patients Receiving gabapentin Expressed as a Difference from Placebo by Dose and Study: Adjunctive Therapy Studies in Patients ≥12 Years of Age with Partial Seizures - image 09
Product Label Images
The following 8 images provide visual information about the product associated with Gabapentin NDC 71610-421 by Aphena Pharma Solutions - Tennessee, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Bottle Label 100 mg - 71610 0421 53
Aphena Pharma Solutions - TN - Aphena
Figure 1 - image 01
This appears to be a table or chart with information about pain scores and medication dosages. The mean pain score is listed as 0, with two different medication regimens (Parkod and Gabapentin) listed with their corresponding dose titration periods and fixed dose periods. The table also includes a baseline week and subsequent weeks.*
Figure 2 - image 02
This appears to be a chart showing the dose and pain score of patients over a 4-week period. The patients are divided into three groups: a placebo group, a group taking Gabapentin at 1800 mg/day and a group taking Gabapentin at 2400 mg/day. The pain score is depicted on a scale from 0 to 10 and was measured at baseline and at the end of weeks 1-7. The chart shows that the mean pain score in each group decreases over time, and that the group taking the higher dose of Gabapentin had the most significant reduction in pain.*
Figure 3 - image 03
Cockcroft and Gault Equation - image 04
Gabapentin Structural Formula - image 05
Figure 4. Responder Rate in Patients Receiving gabapentin Expressed as a Difference from Placebo by Dose and Study: Adjunctive Therapy Studies in Patients ≥12 Years of Age with Partial Seizures - image 09
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
